Today's Edition
ABU DHABI (ALETIHAD)
Cleveland Clinic Abu Dhabi, part of the M42 network, will be participating in the second edition of The Annual UAE Organ Donation and Transplantation Congress, it said on Friday.
The congress, which is scheduled to run from January 27 to 30, 2024 at the Conrad Hotel in Dubai, is organised by Hayat - The National Programme for Donation and Transplantation of Human Organs and Tissue and endorsed by the Ministry of Health and Prevention (MoHAP), the Department of Health – Abu Dhabi (DoH) and the Dubai Health Authority (DHA).
Cleveland Clinic Abu Dhabi is the event’s platinum sponsor.
Uniting global organ and tissue donation and transplantation programs with healthcare professionals, policy makers and researchers, the event aims to support the implementation of innovative solutions that prevent organ failure. Experts will also highlight best practices in organ and tissue transplantation.
During the upcoming congress, visitors to the Cleveland Clinic Abu Dhabi booth will have the opportunity to learn about the lives touched in 2023 by the hospital’s transplant program under ‘Hayat’, as well as its latest innovations in the field of organ transplantation.
Dr. Bashir Sankari, Chair of the Surgical Subspecialties Institute and Head of the Transplant Program at Cleveland Clinic Abu Dhabi said, “We take immense pride in our collaboration with the ‘Hayat’ program, contributing to the broader UAE vision of championing organ donation. As a leading multi-organ transplant center in the UAE, Cleveland Clinic Abu Dhabi plays a crucial role in conducting complex surgeries that employ state-of-the-art technology.”
The hospital has conducted 530 transplants since the program’s inception in 2017 up to the end of 2023. Of these, 192 were completed in 2023 alone – 98 liver, 69 kidney and 16 lung transplants in addition to 9 other organs.
